Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
September 2, 2004
Rituximab
Pratik Multani, Christine A White
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2017
Activity of Entrectinib in a Patient With the First Reported <i>NTRK</i> Fusion in Neuroendocrine Cancer
Darren Sigal, Marie Tartar, Marin Xavier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
Thomas E Witzig, Leo I Gordon, Fernando Cabanillas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
British Journal of Cancer
|
December 4, 2015
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer
Alessio Amatu, Alessio Somaschini, Giulio Cerea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
Molecular Cancer Therapeutics
|
October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms
Kasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
NPJ Precision Oncology
|
June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor
Christopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Blood
|
September 3, 2013
Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation
Corey Cutler, Pratik Multani, David Robbins, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cancer Chemotherapy and Biological Response Modifiers
|
September 2, 2004
Rituximab
Pratik Multani, Christine A White
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2017
Activity of Entrectinib in a Patient With the First Reported <i>NTRK</i> Fusion in Neuroendocrine Cancer
Darren Sigal, Marie Tartar, Marin Xavier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
Thomas E Witzig, Leo I Gordon, Fernando Cabanillas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
British Journal of Cancer
|
December 4, 2015
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer
Alessio Amatu, Alessio Somaschini, Giulio Cerea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
Molecular Cancer Therapeutics
|
October 22, 2017
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms
Kasey L Couts, Judson Bemis, Jacqueline A Turner, et al.
NPJ Precision Oncology
|
June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor
Christopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.
Blood
|
September 3, 2013
Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation
Corey Cutler, Pratik Multani, David Robbins, et al.
Page
of 1